Search

everythinglearnresearchcommunity

for

Search:↓

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Gene network oscillations inside hair stem cells are key for hair growth regulation and could help treat hair loss.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Disrupted cholesterol production impairs hair follicle stem cells, leading to hair loss.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.